Dr. Levitsky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
259 E Erie St
Chicago, IL 60611Phone+1 312-695-4837Fax+1 312-695-0042
Education & Training
- University of Nebraska Medical Center College of MedicineFellowship, Transplant Hepatology, 2003 - 2005
- University of ChicagoFellowship, Gastroenterology, 2001 - 2004
- University of ChicagoResidency, Internal Medicine, 1998 - 2001
- Albert Einstein College of MedicineClass of 1998
Certifications & Licensure
- FL State Medical License 2024 - Present
- IL State Medical License 1998 - 2026
- IA State Medical License 2003 - 2006
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Clinical Trials
- Study of Glycemic Control on Liver Transplantation Outcomes Start of enrollment: 2009 Apr 01
- Proteogenomic Monitoring and Assessment of Liver Transplant Recipients Start of enrollment: 2010 Apr 01
- Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients Start of enrollment: 2012 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 20 citationsThe utility of pulmonary function testing in predicting outcomes following liver transplantation.Leila Kia, Michael J. Cuttica, Amy Yang, Erica Donnan, Maureen Whitsett
Liver Transplantation. 2016-06-01 - 86 citationsA survey of CMV prevention strategies after liver transplantation.Josh Levitsky, Nina Singh, Marilyn M. Wagener, Valentina Stosor, Michael Abecassis
American Journal of Transplantation. 2007-11-05 - 8 citationsImmunosuppressive Drug Levels in Liver Transplant Recipients: Impact in Decision MakingThemistoklis Kourkoumpetis, Josh Levitsky
Seminars in Liver Disease. 2019-04-30
Journal Articles
- Transplanting Livers from HCV‐Infected Donors into HCV‐Negative Recipients: Promise but Mind the PitfallsJosh Levitsky, David S Goldberg, American journal of transplantation
- A Model for Glomerular Filtration Rate Assessment in Liver Disease (GRAIL) in the Presence of Renal DysfunctionBernard Fischbach, James F Trotter, W R Kim, Stevan A Gonzalez, Goran Klintmalm, Sumeet K Asrani, Michael Emmett, Ranjeeta Bahirwani, Josh Levitsky, Mitra K Nadim, Hepatology
- Prevalence and Impact of De Novo DSA During a Multicenter Immunosuppression Withdrawal Trial in Adult Liver Transplant RecipientsSandy Feng, Josh Levitsky, Peter Sayre, Matthew J Everly, Abraham Shaked, Hepatology
Press Mentions
- In the Quest for a Liver Transplant, Patients Are Segregated by Prior Alcohol UseOctober 10th, 2021
- Patients Who Accepted Infected Kidneys Cured of Hepatitis CAugust 7th, 2018
- Antiviral Drug Prevents Recurrence of Hepatitis C in Liver Transplant PatientsJanuary 10th, 2017
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: